3861 results for «2596»
3861 results
TAV in TAV for an 8-year old degenerating TAVI device - Session with LIVE case
19 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom
Controversy - Challenges for the Heart Team II - Mitral regurgitation and heart failure - Where two worlds meet
19 Nov 2019 – From PCR London Valves 2019
Consult this session on mitral regurgitation and heart failure to hear the latest thinking concerning the optimal management of patients suffering from these diseases, and discover the implications of recent trials for your clinical practice, such as COAPT, MITRA-FR, and more!
TAVI in bicuspid aortic valve disease - Session with LIVE case
19 Nov 2019 – From PCR London Valves 2019
Watch this session with LIVE demonstration from Clinique Pasteur - Toulouse, France
TAVI: management of unusual complications
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about how to manage the following unusual TAVI complications: wire entrapment in hypertrabecular left ventricle after aortic valve release, iatrogenic VSD after TAVI in a patient with bicuspid severe aortic stenosis, ruptured pseudoaneurysm of the mitral-aortic intervalvular fibrosa, unsuccessful TAVI in...
GulfPCR-GIM 2019 Opening Ceremony
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover the slides presented during GulfPCR-GIM 2019 Opening Ceremony, the leading-edge interventional course in the Middle East, and learn more about the course directors, the programme committee members, the sessions and the live centers.
How to treat a patient with challenging STEMI scenarios?
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn how to deal with challenging primary PCI in various STEMI scenarios (LV aneurysm, acute pulmonary embolism...), how to manage unorthodox presentations (such as an arterial lusoria), and how to deal with primary PCI complications (such as a thrombus), thanks to a selection of complex clinical...
Complex and challenging cases I
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn how to manage complex complications, with a selection of challenging clinical cases such as: high-risk left main artery, stent ablation and rota-stenting, LT main lesion, and more!
My five top trials in interventional cardiology in 2019: impact on clinical practice?
02 Jan 2020 – From GulfPCR-GIM 2020
Consult this session to learn all about the latest evidence from trials relevant for interventional cardiology, selected by EAPCI President Andreas Baumbach, and discover their impact on your daily practice: COMPLETE, BIOSTEMI, EXCEL, and more!
Complex and challenging cases II
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover how to safely manage difficult complications, thanks to a selection of complex clinical cases: ascending aortic dissection, balloon rupture, retrograde PCI on CTO of ostial right coronary artery, and more!
GulfPCR-GIM 2019 Award and Closing Ceremony
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to see the slides presented during GulfPCR-GIM 2019 Award and Closing Ceremony, which gathered 832 active participants, and discover who the best clinical case award winner was that year.
Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn how to use IVUS to guide vessel preparation and size stents and assess angioplasty results, how SyncVision IVUS co-registration can improve efficiency of angioplasty, and how iFR co-registration can guide angioplasty in patients with diffuse disease.
Novel approach in the management of severely calcified lesions
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session dedicated to the Diamondback 360 coronary orbital atherectomy system to learn more about how this tool optimise the outcomes for coronary lesion preparation, how orbital atherectomy may fit into your daily practice, and what is the "must have" tool box for calcified coronary lesions.
PCI optimisation: OCT and physiology in a complex multivessel disease case
18 Dec 2019 – From GulfPCR-GIM 2019
The patient is a 57-year-old male with high-risk factors and previous history of revascularisation. He presents with ischemic chest pain with NSTE-ACS. The baseline angiography shows multivessel disease and calcified LAD/D1 bifurcation (1,1,0).
The key objectives of this case are:
- Utility of FFR in physiological assessment of a...
Updates in TAVI therapies
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn more about the latest updates in TAVI therapies, and discover the unique features of Acurate neo and Lotus Edge, the clinical evidence of both Boston Scientific TAVI platforms, while learning all about the needs of cerebral protection during TAVI procedures.
All you need to know to start optimising outcomes in PCI: OCT and physiology
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session on the new developments and future directions in functional coronary assessment to discover how and why physiology assessment/OCT could optimise procedural outcomes in PCI, and learn all about their main indications, the relevant indicators to be assessed, as well as the last changes...
Shaping the future of transcatheter valve interventions
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
Shaping care pathways for severe aortic stenosis patients in a COVID-19 context
Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.
